Apellis Pharmaceuticals, Inc. APLS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

48/100

1/7 Pass

SharesGrow Intrinsic Value

Apellis Pharmaceuticals, Inc. (APLS) has 20 已知的内部人和机构持有人记录. 最大持有人为 Morningside Venture Investments Ltd 持有 12,806,342 股. 其他重要持有人包括 Deschatelets Pascal 和 Francois Cedric.

过去12个月，内部人进行了 86 笔交易，涉及 APLS 股票 — 32 笔买入 (价值为 $19.26M) 和 39 笔卖出 (价值为 $10.82M). 内部人卖出超过买入.

APLS 內部人持股

最大持股人

Morningside Venture Investments Ltd

12,806,342 股

买入（12个月）

$19.26M 价值

卖出（12个月）

$10.82M 价值

12个月交易活动

买入 37%

卖出 45%

主要內部人持股

#	姓名	职位	持股数量	最近申报日期	相对规模
1	Morningside Venture Investments Ltd	10 Percent Owner	12,806,342	2021-11-18	100%
2	Deschatelets Pascal	Chief Scientific Officer	1,177,222	2026-01-30	9%
3	Francois Cedric	Chief Executive Officer	372,815	2026-03-13	3%
4	Sullivan Timothy Eugene	Chief Financial Officer	152,041	2026-01-30	1%
5	Watson David O.	General Counsel	144,517	2026-01-30	1%
6	Boucher Kelley	Chief People Officer	127,804	2026-01-30	1%
7	Nicholson Nur	Chief Technical Officer	116,338	2026-01-30	1%
8	Delong Mark Jeffrey	Chief Business & Strat Officer	114,591	2026-02-13	1%
9	Meltzer Leslie	Chief Research and Development	107,024	2026-01-30	1%
10	Grossi Federico	Chief Medical Officer	94,884	2023-01-09	1%
11	Baumal Caroline	Chief Medical Officer	86,527	2026-01-23	1%
12	Townsend Adam J.	Chief Commercial Officer	84,050	2025-01-30	1%
13	Lewis Karen	Chief People Officer	70,251	2025-01-30	1%
14	Chopas James George	VP/chief Accounting Officer	65,955	2026-01-30	1%
15	Eisele Jeffrey	Chief Development Officer	55,312	2025-01-30	0%
16	Scheibler Lukas	Chief Research Officer	39,391	2023-12-05	0%
17	Brown Victoria L.	Program Team Lead	23,556	2023-01-24	0%
18	Walbert Keli	Director	14,684	2026-01-05	0%
19	Wheeler Craig A	Director	14,684	2026-01-05	0%
20	Machiels Alec	Director	14,684	2026-01-05	0%

近期交易 (过去12个月)

日期	姓名	职位	类型	股数	股价	总价值
2026-03-31	Biogen Inc.	Other: See Footnotes	未知	-	-	-
2026-03-11	Francois Cedric	Chief Executive Officer	赠与（收到）	64,869	-	-
2026-03-02	Dolsten Mikael	Director	未知	-	-	-
2026-02-27	Dolsten Mikael	Director	限制性股票授予 (RSU)	14,312	-	-
2026-02-11	Delong Mark Jeffrey	Chief Business & Strat Officer	知情卖出	368	$22.15	$8.15K
2026-02-03	Francois Cedric	Chief Executive Officer	期权行权（卖出）	8,840	$3.76	$33.24K
2026-01-28	Meltzer Leslie	Chief Research and Development	限制性股票授予 (RSU)	45,220	-	-
2026-01-28	Boucher Kelley	Chief People Officer	限制性股票授予 (RSU)	30,146	-	-
2026-01-28	Delong Mark Jeffrey	Chief Business & Strat Officer	限制性股票授予 (RSU)	36,606	-	-
2026-01-28	Chopas James George	VP/chief Accounting Officer	限制性股票授予 (RSU)	16,150	-	-
2026-01-28	Nicholson Nur	Chief Technical Officer	限制性股票授予 (RSU)	45,220	-	-
2026-01-28	Sullivan Timothy Eugene	Chief Financial Officer	限制性股票授予 (RSU)	58,140	-	-
2026-01-28	Francois Cedric	Chief Executive Officer	限制性股票授予 (RSU)	195,952	-	-
2026-01-28	Deschatelets Pascal	Chief Scientific Officer	限制性股票授予 (RSU)	25,840	-	-
2026-01-28	Watson David O.	General Counsel	限制性股票授予 (RSU)	55,986	-	-
2026-01-22	Baumal Caroline	Chief Medical Officer	知情卖出	2,797	$21.77	$60.88K
2026-01-22	Delong Mark Jeffrey	Chief Business & Strat Officer	知情卖出	3,371	$21.77	$73.37K
2026-01-22	Chopas James George	VP/chief Accounting Officer	知情卖出	2,064	$21.77	$44.92K
2026-01-22	Nicholson Nur	Chief Technical Officer	知情卖出	7,725	$21.77	$168.14K
2026-01-22	Sullivan Timothy Eugene	Chief Financial Officer	知情卖出	10,287	$21.77	$223.9K
2026-01-22	Francois Cedric	Chief Executive Officer	知情卖出	27,192	$21.77	$591.84K
2026-01-22	Deschatelets Pascal	Chief Scientific Officer	知情卖出	5,928	$21.77	$129.03K
2026-01-22	Watson David O.	General Counsel	知情卖出	7,832	$21.77	$170.47K
2026-01-20	Baumal Caroline	Chief Medical Officer	知情卖出	1,882	$19.79	$37.25K
2026-01-20	Delong Mark Jeffrey	Chief Business & Strat Officer	知情卖出	1,334	$19.79	$26.4K